Yttrium-90 microspheres are radioactive particles which are increasingly being employed for
treating patients with unresectable hepatocellular carcinoma (HCC). The procedure is called …

Liver malignancy, including primary liver cancer and metastatic liver cancer, has become
one of the most common causes of cancer-related death worldwide due to the high …

Hepatocellular carcinoma (HCC) constitutes a difficult health challenge because of its poor
prognosis and limited treatment options. Most available therapies are used only for …

(1) Microspheres containing radioactive yttrium-90 (90Y) are infused into the hepatic artery.
These deliver high doses of ionizing radiation to inoperable hepatocellular carcinoma, the …

Methods. Ten patients with primary hepatocellular carcinoma were treated with intraarterial
instillation of yttrium‐90 (Y‐90) microspheres, including eight men and two women (median …

Background: Many patients with liver malignancies are not candidates for resection, and
systemic therapies are often not effective. Radioembolization (RE) is an alternative treatment …

Unresectable hepatocellular carcinoma is extremely difficult to treat. TheraSphere consists
of yttrium-90 (a pure beta emitter) microspheres, which are injected into the hepatic arteries …

A small percentage of patients with hepatocellular carcinoma (HCC) are candidates for
curative treatment in form of resection or transplantation. There are different treatment …

To present a critical review of yttrium-90 (TheraSphere) for the treatment of hepatocellular
carcinoma (HCC). Medical literature databases (Medline, Cochrane Library, and …

PURPOSE: Intraarterial injection of yttrium 90 microspheres (TheraSpheres) is used in the
treatment of hepatocellular carcinoma (HCC). This article presents an analysis of the …